David K Donald

Title: David K. Donald: Innovator in Collagenase Inhibition

Introduction

David K. Donald is a notable inventor based in High Wycombe, GB. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of collagenase inhibitors. With a total of 4 patents to his name, his work has the potential to impact the treatment of various collagenase-induced diseases.

Latest Patents

Among his latest patents is a groundbreaking invention titled "Hydroxamic acid based collagenase inhibitors." This disclosure relates to a novel class of hydroxamic acid-based collagenase inhibitor derivatives. The patent further details pharmaceutical compositions containing such compounds and their use in treating collagenase-induced diseases. Another significant patent is for an "Intermediate for thiol based collagenase inhibitors." This invention involves compounds that serve as intermediates in the preparation of collagenase inhibiting compounds, which are useful in treating arthritis.

Career Highlights

David K. Donald has been associated with G.D. Searle & Company, where he has contributed to various innovative projects. His expertise in the field of collagenase inhibitors has positioned him as a key figure in pharmaceutical research and development.

Collaborations

Throughout his career, David has collaborated with notable colleagues, including Jonathan P. Dickens and Geoffrey Kneen. These collaborations have further enhanced the scope and impact of his research.

Conclusion

David K. Donald's work in the field of collagenase inhibition showcases his innovative spirit and dedication to advancing pharmaceutical science. His contributions are poised to make a significant difference in the treatment of diseases related to collagenase.